Provided by Tiger Trade Technology Pte. Ltd.

AxoGen

30.78
-0.3800-1.22%
Post-market: 30.780.00000.00%19:32 EDT
Volume:1.64M
Turnover:50.71M
Market Cap:1.60B
PE:-90.26
High:31.47
Open:31.38
Low:30.65
Close:31.16
52wk High:36.00
52wk Low:9.22
Shares:51.90M
Float Shares:45.24M
Volume Ratio:1.58
T/O Rate:3.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3410
EPS(LYR):-0.3410
ROE:-13.49%
ROA:-2.31%
PB:12.40
PE(LYR):-90.26

Loading ...

AxoGen Inc : Canaccord Genuity Raises Target Price to $37 From $27

THOMSON REUTERS
·
Dec 05, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Raymond James, CAVA, Paramount Skydance

Reuters
·
Dec 05, 2025

Axogen Is Maintained at Buy by Lake Street

Dow Jones
·
Dec 05, 2025

Sector Update: Health Care Stocks Edge Higher Pre-Bell Thursday

MT Newswires Live
·
Dec 04, 2025

AxoGen Inc : Jefferies Raises Target Price to $36 From $29

THOMSON REUTERS
·
Dec 04, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Salesforce, Dollar General, gold miners

Reuters
·
Dec 04, 2025

AxoGen Shares Rise 6.8% Premarket After FDA Approves Co's Nerve Repair Graft

THOMSON REUTERS
·
Dec 04, 2025

BRIEF-Axogen Announces FDA Approval Of Biologics License Application For Avance (Acellular Nerve Allograft–Arwx)

Reuters
·
Dec 04, 2025

AxoGen Announces FDA Approval of Biologics License Application for Avance® (Acellular Nerve Allograft–Arwx)

THOMSON REUTERS
·
Dec 04, 2025

AxoGen Inc - Commercial Availability of Licensed Avance Product Is Expected Early in Q2 of 2026

THOMSON REUTERS
·
Dec 04, 2025

FDA approves Axogen's nerve repair graft

Reuters
·
Dec 04, 2025

AxoGen Inc : Mizuho Initiates Coverage With Outperform Rating; Target Price $40

THOMSON REUTERS
·
Dec 01, 2025

U.S. RESEARCH ROUNDUP-Air Products, Hanover Insurance, Kinsale Capital

Reuters
·
Nov 25, 2025

AxoGen Inc : Leerink Partners Raises Target Price to $33 From $28

THOMSON REUTERS
·
Nov 25, 2025

Jefferies Remains a Buy on AxoGen (AXGN)

TIPRANKS
·
Nov 24, 2025

Axogen Inc. Director William P. Burke Reports Disposal of Common Shares

Reuters
·
Nov 14, 2025

Axogen Inc. Director William P. Burke Reports Disposal of Common Shares

Reuters
·
Nov 08, 2025

Axogen Inc. to Present at Piper Sandler Annual Healthcare Conference

Reuters
·
Nov 04, 2025

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

GlobeNewswire
·
Nov 04, 2025

Axogen Inc. Director William P. Burke Reports Disposal of Common Shares

Reuters
·
Nov 01, 2025